Simulated microgravity increases CD226+ Lin- CD117- Sca1+ mesenchymal stem cells in mice

© 2024 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society..

Microgravity is one of the most common causes counting for the bone loss. Mesenchymal stem cells (MSCs) contribute greatly to the differentiation and function of bone related cells. The development of novel MSCs biomarkers is critical for implementing effective therapies for microgravity induced bone loss. We aimed to find the new molecules involved in the differentiation and function of MSCs in mouse simulated microgravity model. We found CD226 was preferentially expressed on a subset of MSCs. Simulation of microgravity treatment significantly increased the proportion of CD226+ Lin- CD117- Sca1+ MSCs. The CD226+ MSCs produced higher IL-6, M-CSF, RANKL and lower CD200 expression, and promoted osteoclast differentiation. This study provides pivotal information to understand the role of CD226 in MSCs, and inspires new ideas for prevention of bone loss related diseases.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Physiological reports - 12(2024), 5 vom: 14. März, Seite e15971

Sprache:

Englisch

Beteiligte Personen:

Zhou, Wenjing [VerfasserIn]
Li, Yi [VerfasserIn]
Hou, Yongli [VerfasserIn]
Dan, Wenli [VerfasserIn]
Chen, Lihua [VerfasserIn]
Shi, Fei [VerfasserIn]
Zhao, Fang [VerfasserIn]
Fang, Liang [VerfasserIn]

Links:

Volltext

Themen:

Biomarker
CD226
Journal Article
Mesenchymal stem cell
Simulated microgravity

Anmerkungen:

Date Completed 13.03.2024

Date Revised 14.03.2024

published: Print

Citation Status MEDLINE

doi:

10.14814/phy2.15971

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369572831